Answers are grounded in this paper and cite their sources.
Nonprecious-metal-catalyzed alternatives to powerful precious metal transformations are of increasing interest in academia and the pharmaceutical industry due to the lower cost, better sustainability, and lower toxicity. With the continual growth in the broad field of nonprecious metal catalysis (NPMC), we have chosen to highlight selected articles published from March to June 2022 which are intended to highlight examples of NPMC that we feel may be especially relevant to pharmaceutical development. We aim to inspire academic and industrial innovation in NPMC through the discussion herein.
No takes yet. Share an insight, caveat, or question.
Haibach et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: